This study revealed that the minor alleles at rs10069690 and at rs2242652 were candidate causal variants for risk of estrogen receptor-negative breast cancer, breast cancer in BRCA1 mutation carriers, serous low malignant potential ovarian cancer and serous invasive ovarian cancer with odds ratios ranging from 1.15–1.40 [13,24] and for risk of prostate cancer [13,24]. The gene discussed is BRCA1; the disease is breast carcinoma.